PharmaResearch (214450.KQ) Earnings Analysis
PharmaResearch (214450.KQ) next reports earnings on 2026-08-07, consensus EPS 4,043.92 KRW. Last quarter (2026-05-08) it beat with EPS 3,733.32 KRW vs 3,557.03 KRW est (+5%). It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E 21.19.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 214450.KQ next report earnings?
| Next earnings date | 2026-08-07 |
|---|---|
| Consensus EPS estimate | 4,043.92 KRW |
| Revenue estimate | 166.74B |
214450.KQ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-08 | 3,733.32 KRW | 3,557.03 KRW | +5% | Beat |
| 2026-02-04 | 2,583.38 KRW | 3,686.32 KRW | -29.9% | Miss |
| 2025-08-08 | 4,098.95 KRW | n/a | n/a | n/a |
| 2025-03-13 | 1,771.6 KRW | n/a | n/a | n/a |
Beat rate: 1/2 (50%) over reported quarters with consensus data.
214450.KQ valuation and analyst view
| Trailing P/E | 21.19 |
|---|---|
| Trailing EPS | 16,581.02 KRW |
| Price / book | 5.50 |
| Dividend yield | 0.31% |
| Market cap | 3350.66B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is PharmaResearch (214450.KQ)'s next earnings date?
PharmaResearch is next scheduled to report on 2026-08-07, with a consensus EPS estimate of 4043.92 KRW and revenue estimate of 166.74B.
Did 214450.KQ beat earnings last quarter?
In its 2026-05-08 report, 214450.KQ posted EPS of 3733.32 KRW versus a 3557.03 KRW estimate — a beat of 5%.
What is 214450.KQ's earnings track record?
Over the last 2 reported quarters with consensus data, 214450.KQ beat estimates 1 times (50%).
What is 214450.KQ's current P/E ratio and EPS?
214450.KQ trades at a trailing P/E of 21.19 on trailing EPS of 16581.018034942703 KRW.
What do analysts rate 214450.KQ?
214450.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.